Dr. Hale is the Founder of Medicines360, a pharmaceutical scientist and global health social entrepreneur. Her passion is the development of important new medicines for all of humanity, with the specific goal to reduce health inequities. 

Dr. Hale is Founder & Chair Emeritus of One World Health, the first nonprofit pharmaceutical company in the US. She founded the company in 2000 and served as its first Chairman and CEO (2000-2008). Under her leadership the organization developed a new cure for visceral leishmaniasis, launched a novel approach to treat dehydrating diarrhea, and developed a platform technology to reduce the cost of malaria drugs by more than 10-fold. 

Dr. Hale established her expertise in all stages of biopharmaceutical drug development at the US Food and Drug Administration (FDA), and at Genentech. 

She earned her PhD in Pharmaceutical Chemistry from University of California San Francisco, where she presently maintains an Adjunct Associate Professorship in Biopharmaceutical Sciences. 

Her recent honors include being elected to membership in the Institute of Medicine of the US National Academies (2007), and being granted the MacArthur “Genius” Award (2006). She received the President’s Award of Distinction from the American Association of Pharmaceutical Scientists. She is internationally recognized as a senior social entrepreneur by the Skoll Foundation, Schwab Foundation, and Ashoka. The Economist named Hale the recipient of its Social and Economic Innovation Award (2005).